Solana Beach, CA, United States of America

Carl F Ware

USPTO Granted Patents = 19 (Patent Applications = 3)

CIPO Patents = 1 (Patent Applications = 3)

EPO Patents = 5 (Patent Applications = 2)

Average Co-Inventor Count = 2.4

ph-index = 5

Forward Citations = 61(Granted Patents)

Location History:

La Jolla, CA (US) (2018 - 2022)
Solana Beach, CA (US) (2006 - 2024)

Company Filing History:

12 out of 59

La Jolla Institute for Allergy and Immunology

patents

6 out of 88

Sanford Burnham Prebys Medical Discovery Institute

patents

3 out of 272

Kyowa Hakko Kirin Co., Limited

Sanford-burnham Medical Research Institute

patents

where one patent can have more than one assignee

Years Active: 2006-2024

Loading Chart...

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11939367 - BTLA fusion protein agonists and uses thereof (2024-03-26),

2. 11365221 - Compositions and methods for treating autoimmune and inflammatory disorders (2022-06-21),

3. 11352428 - Modulation of immune response using BTLA agonist antibodies (2022-06-07),

4. 10961297 - BTLA fusion protein agonists and uses thereof (2021-03-30),

5. 10759863 - Modulation of γδ T cells (2020-09-01),

6. 10717765 - Compositions and methods for treating autoimmune and inflammatory disorders (2020-07-21),

7. 10220081 - Methods of modulating HVEM, BTLA and CD160 cis complex response or signaling activity with soluble light polypeptide sequences (2019-03-05),

8. 10106619 - Virus vaccination and treatment methods with OX40 agonist compositions (2018-10-23),

9. 9982023 - Compositions and methods for treating autoimmune and inflammatory disorders (2018-05-29),

10. 9771419 - Antagonistic human light-specific human monoclonal antibodies (2017-09-26),

11. 9700606 - HVEM/BTLA, HVEM/CD 160 and HVEM/gD cis complexes and methods of use (2017-07-11),

12. 9694058 - Light-mediated anti-cell proliferative compositions and methods (2017-07-04),

13. 8974787 - Antagonistic human light-specific human monoclonal antibodies (2015-03-10),

14. 8461307 - Antagonistic human LIGHT-specific human monoclonal antibodies (2013-06-11),

15. 8349320 - Compositions and methods for modulating responses mediated or associated with BTLA activity (2013-01-08),

Title: Unveiling the Inventor Extraordinaire: Carl F Ware

Introduction:

Meet the brilliant mind behind 19 groundbreaking patents, Carl F Ware, hailing from the sunny Solana Beach, CA. His innovative spirit and dedication have led to remarkable contributions in the field of immunology and medical research.

Latest Patents:

Among his latest patents is the revolutionary "BTLA fusion protein agonists and uses thereof," which focuses on leveraging BTLA agonist fusion proteins to modulate immune responses and treat cancer, immune, and inflammatory diseases. Additionally, his work on "Compositions and methods for treating autoimmune and inflammatory disorders" showcases ligand-specific HVEM variants for treating inflammatory diseases through innovative compositions.

Career Highlights:

Carl F Ware has left an indelible mark at institutions like La Jolla Institute for Allergy and Immunology and Sanford Burnham Prebys Medical Discovery Institute. His visionary leadership and scientific acumen have not only inspired his peers but have also propelled the boundaries of medical research.

Collaborations:

Throughout his illustrious career, Carl F Ware has collaborated with esteemed professionals such as John Sedy and Steven W Granger. Together, they have synergized their expertise to drive innovation and create transformative solutions in the realm of immunology.

Conclusion:

In conclusion, Carl F Ware's relentless pursuit of excellence and unwavering commitment to advancing medical science stand as a testament to his ingenuity. His patents and collaborations underscore his significant contributions to the field, making him a revered figure in the world of innovation and invention.

This text is generated by artificial intelligence and may not be accurate.